UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

SOCCAR: A randomised phase II trial comparing sequential versus concurrent chemotherapy and radical hypofractionated radiotherapy in patients with inoperable stage III Non-Small Cell Lung Cancer and good performance status

European journal of cancer (1990), 2014-11, Vol.50 (17), p.2939-2949

2014

Volltextzugriff (PDF)

Optimising Radium 223 Therapy for Metastatic Castration-Resistant Prostate Cancer –5-year Real-World Outcome: Focusing on Treatment Sequence and Quality of Life

Clinical oncology (Royal College of Radiologists (Great Britain)), 2020-10, Vol.32 (10), p.e177-e187

2020

Volltextzugriff (PDF)

Hypofractionated Concomitant Chemoradiation in Inoperable Locally Advanced Non-small Cell Lung Cancer: A Report on 100 Patients and a Systematic Review

Clinical oncology (Royal College of Radiologists (Great Britain)), 2019-02, Vol.31 (2), p.e1-e10

2019

Volltextzugriff (PDF)

131 Preliminary results of prospective data for patients receiving stereotactic ablative radiotherapy (SABR) for early stage non-small cell lung cancer (NSCLC)

Lung cancer (Amsterdam, Netherlands), 2016, Vol.91, p.S47-S48

2016

Volltextzugriff (PDF)

2632 VICTOR: Vinflunine in advanced metastatic transitional cell carcinoma of the urothelium (TCCU): A retrospective analysis of the use of Vinflunine in a multi-centre real life setting as second line chemotherapy through the free of charge programme (FOCP) for patients in the UK

European journal of cancer (1990), 2015-09, Vol.51, p.S523-S523

2015

Volltextzugriff (PDF)

142 Concurrent chemoradiation for lung cancer in a North of England population – are we managing toxicities appropriately?

Lung cancer (Amsterdam, Netherlands), 2014, Vol.83, p.S52-S52

2014

Volltextzugriff (PDF)

155 Multi-modality treatment of Pancoast tumours: a review of regional practice

Lung cancer (Amsterdam, Netherlands), 2014, Vol.83, p.S57-S57

2014

Volltextzugriff (PDF)

137 10 years of CHART (continuous hyperfractionated accelerated radiotherapy) for non-small cell lung cancer (NSCLC) at NCCC

Lung cancer (Amsterdam, Netherlands), 2016, Vol.91, p.S50-S50

2016

Volltextzugriff (PDF)

142: CONVERT – An international randomised trial of concurrent chemo-radiotherapy (cCTRT) comparing twice-daily (BD) and once-daily (OD) radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status (PS)

Lung cancer (Amsterdam, Netherlands), 2017, Vol.103, p.S64-S64

2017

Volltextzugriff (PDF)

57 Crizotinib in clinical practice: the North East of England's experience

Lung cancer (Amsterdam, Netherlands), 2016, Vol.91, p.S21-S21

2016

Volltextzugriff (PDF)

144 A comparison of pre-trial QA versus ongoing QA for the CONVERT trial

Lung cancer (Amsterdam, Netherlands), 2014, Vol.83, p.S53-S53

2014

Volltextzugriff (PDF)

143 A review of changes in lung radiotherapy treatment techniques during the CONVERT trial

Lung cancer (Amsterdam, Netherlands), 2014, Vol.83, p.S52-S52

2014

Volltextzugriff (PDF)

Outcome of Radium-223 in metastatic castrate resistant prostate cancer: an audit to assess real life experience at the Northern Centre for Cancer Care, Newcastle-upon-Tyne

Clinical oncology (Royal College of Radiologists (Great Britain)), 2015-06, Vol.27, p.S5-S5

2015

Volltextzugriff (PDF)

166 Thoracic radiotherapy in extensive-disease small cell lung cancer: a retrospective review

Lung cancer (Amsterdam, Netherlands), 2012, Vol.75, p.S55-S55

2012

Volltextzugriff (PDF)

166: REST – a Dutch/UK randomized phase III trial on the use of thoracic radiotherapy in extensive stage small-cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2015, Vol.87, p.S60-S61

2015

Volltextzugriff (PDF)

72: Audit of outcomes of NSCLC patients treated with first line EGFR inhibitors in North East England

Lung cancer (Amsterdam, Netherlands), 2015, Vol.87, p.S28-S28

2015

Volltextzugriff (PDF)

Recent advances and future directions in the management of metastatic renal cell carcinoma

Anti-cancer agents in medicinal chemistry, 2010-03, Vol.10 (3), p.225-235

2010

Volltextzugriff (PDF)

159 Prospective data of continuous hyperfractionated accelerated radiotherapy (CHART) for non-small cell lung cancer (NSCLC) in North East cancer centre

Lung cancer (Amsterdam, Netherlands), 2013, Vol.79, p.S54-S54

2013

Volltextzugriff (PDF)

144 Prospective data of continuous hyperfractionated accelerated radiotherapy (CHART): does performance status have an impact on radiation acute toxicities and resources?

Lung cancer (Amsterdam, Netherlands), 2012, Vol.75, p.S47-S47

2012

Volltextzugriff (PDF)

EP-1230 ASSESSING ACUTE RADIATION OESOPHAGITIS AFTER CHART FOR NON-SMALL CELL LUNG CANCER: A SINGLE CENTRE EXPERIENCE

Radiotherapy and oncology, 2012-05, Vol.103, p.S472-S472

2012

Volltextzugriff (PDF)

Guidelines for the diagnosis, prevention and management of chemical- and radiation-induced cystitis

Journal of clinical urology, 2014-01, Vol.7 (1), p.25-35

2014

Volltextzugriff (PDF)

185 CONVERT – a successful international collaboration between the UK NCRI, Groupe Français de Pneumo-Cancérologie, Spanish Lung Cancer Group, EORTC and NCI Canada

Lung cancer (Amsterdam, Netherlands), 2014, Vol.83, p.S69-S69

2014

Volltextzugriff (PDF)

Bone Health Management in Advanced Prostate Cancer: a Survey of UK Genitourinary Healthcare Professionals (GU HCPs)

Clinical oncology (Royal College of Radiologists (Great Britain)), 2024-01, Vol.36 (1), p.e79

2024

Volltextzugriff (PDF)

Quality-of-life outcomes in metastatic spinal cord compression: findings from the SCORAD trial

JNCI : Journal of the National Cancer Institute, 2024-07, Vol.116 (7), p.1087-1094

2024

Volltextzugriff (PDF)

137 Prospective quality of life measurement in SOCCAR no disadvantage for patients receiving concurrent vs sequential treatment with 55Gy/20f and cisplatinum/vinorelbine

Lung cancer (Amsterdam, Netherlands), 2012, Vol.75, p.S45-S45

2012

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(69)

Publikationsform

Artikel
(72)

Sprache

Englisch
(72)

Erscheinungsjahr

n.n

Thema

Hematology, Oncology And Palliative Medicine
(33)
Pulmonary/respiratory
(23)
Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Humans
(19)
Oncology
(14)
Male
(12)
Middle Aged
(11)
Aged
(9)
Female
(9)
Biological And Medical Sciences
(8)
Medical Sciences
(8)
Adult
(4)
Antineoplastic Agents - Therapeutic Use
(4)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)
Chemotherapy
(4)
Pharmacology. Drug Treatments
(4)
Quality Of Life
(4)
Radiology
(4)
Treatment Outcome
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

SOCCAR: A randomised phase II trial comparing sequential versus concurrent chemotherapy and radical hypofractionated radiotherapy in patients with inoperable stage III Non-Small Cell Lung Cancer and good performance status

Optimising Radium 223 Therapy for Metastatic Castration-Resistant Prostate Cancer –5-year Real-World Outcome: Focusing on Treatment Sequence and Quality of Life

Hypofractionated Concomitant Chemoradiation in Inoperable Locally Advanced Non-small Cell Lung Cancer: A Report on 100 Patients and a Systematic Review

131 Preliminary results of prospective data for patients receiving stereotactic ablative radiotherapy (SABR) for early stage non-small cell lung cancer (NSCLC)

2632 VICTOR: Vinflunine in advanced metastatic transitional cell carcinoma of the urothelium (TCCU): A retrospective analysis of the use of Vinflunine in a multi-centre real life setting as second line chemotherapy through the free of charge programme (FOCP) for patients in the UK

142 Concurrent chemoradiation for lung cancer in a North of England population – are we managing toxicities appropriately?

155 Multi-modality treatment of Pancoast tumours: a review of regional practice

137 10 years of CHART (continuous hyperfractionated accelerated radiotherapy) for non-small cell lung cancer (NSCLC) at NCCC

142: CONVERT – An international randomised trial of concurrent chemo-radiotherapy (cCTRT) comparing twice-daily (BD) and once-daily (OD) radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status (PS)

57 Crizotinib in clinical practice: the North East of England's experience

144 A comparison of pre-trial QA versus ongoing QA for the CONVERT trial

143 A review of changes in lung radiotherapy treatment techniques during the CONVERT trial

Outcome of Radium-223 in metastatic castrate resistant prostate cancer: an audit to assess real life experience at the Northern Centre for Cancer Care, Newcastle-upon-Tyne

166 Thoracic radiotherapy in extensive-disease small cell lung cancer: a retrospective review

166: REST – a Dutch/UK randomized phase III trial on the use of thoracic radiotherapy in extensive stage small-cell lung cancer

72: Audit of outcomes of NSCLC patients treated with first line EGFR inhibitors in North East England

Recent advances and future directions in the management of metastatic renal cell carcinoma

159 Prospective data of continuous hyperfractionated accelerated radiotherapy (CHART) for non-small cell lung cancer (NSCLC) in North East cancer centre

144 Prospective data of continuous hyperfractionated accelerated radiotherapy (CHART): does performance status have an impact on radiation acute toxicities and resources?

EP-1230 ASSESSING ACUTE RADIATION OESOPHAGITIS AFTER CHART FOR NON-SMALL CELL LUNG CANCER: A SINGLE CENTRE EXPERIENCE

Guidelines for the diagnosis, prevention and management of chemical- and radiation-induced cystitis

185 CONVERT – a successful international collaboration between the UK NCRI, Groupe Français de Pneumo-Cancérologie, Spanish Lung Cancer Group, EORTC and NCI Canada

Bone Health Management in Advanced Prostate Cancer: a Survey of UK Genitourinary Healthcare Professionals (GU HCPs)

Quality-of-life outcomes in metastatic spinal cord compression: findings from the SCORAD trial

137 Prospective quality of life measurement in SOCCAR no disadvantage for patients receiving concurrent vs sequential treatment with 55Gy/20f and cisplatinum/vinorelbine

Suchergebnisse filtern